Pertussis Vaccine Market Size, Share, and Growth Analysis, By Product Type, By Vaccine Type, By Application, By End User, By Region - Industry Forecast 2026-2033

Global Pertussis Vaccine Market size was valued at USD 5.07 Billion in 2024 and is poised to grow from USD 5.26 Billion in 2025 to USD 7.09 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The global pertussis vaccine market is poised for significant growth due to the harmonization of regulatory frameworks across various economies. This trend facilitates quicker market entry and reduces development costs for manufacturers, resulting in higher investments in vaccine candidates. Streamlined approval processes by key regulatory bodies enhance the attractiveness of acellular formulations, exemplified by strategic partnerships between biotech firms and vaccine manufacturers in emerging markets. Such collaborations not only expand access to at-risk populations but also create robust revenue streams that support resilience and foster research and development initiatives within the sector, ultimately driving the market forward and improving public health outcomes worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pertussis Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pertussis Vaccine Market Segments Analysis

Global pertussis vaccine market is segmented by product type, vaccine type, application, end user and region. Based on product type, the market is segmented into DTaP (diphtheria, tetanus, acellular pertussis), Tdap (tetanus, diphtheria, pertussis (adult booster)), whole-cell pertussis vaccines (wP) and combination vaccines (including pertussis antigen). Based on vaccine type, the market is segmented into acellular pertussis (aP) and whole-cell pertussis (wP). Based on application, the market is segmented into pediatric immunization, adolescent booster, adult booster and maternal immunization. Based on end user, the market is segmented into hospitals & clinics, government immunization programs and private healthcare facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pertussis Vaccine Market

The Global Pertussis Vaccine market is experiencing significant growth driven by heightened public awareness of the severe complications associated with pertussis, especially among newborns. As health campaigns and media reports shed light on this issue, both parents and healthcare providers are becoming increasingly focused on ensuring vaccinations are administered. This demand for safe and effective pertussis vaccines is encouraging manufacturers to enhance their production capabilities and innovate new formulations. As the overall immunization framework gains broader acceptance, this creates a positive feedback loop, facilitating growth across various regions and enabling improved public health outcomes and sustained disease control initiatives.

Restraints in the Global Pertussis Vaccine Market

The global market for pertussis vaccines is hindered by ongoing concerns among certain caregiver groups regarding vaccine safety, coupled with misconceptions surrounding pertussis immunization. These apprehensions result in delays or outright refusals in vaccination schedules, ultimately diminishing overall market demand. The lack of confidence in vaccines discourages investment in new product development and hampers the success of public health initiatives aimed at controlling the disease. Consequently, manufacturers encounter unpredictable sales patterns, while healthcare systems must allocate additional resources for educational campaigns, stifling market growth. This uncertainty also complicates long-term planning for distribution networks, requiring companies to adjust their inventory strategies based on varying regional uptake.

Market Trends of the Global Pertussis Vaccine Market

The Global Pertussis Vaccine market is witnessing a notable trend towards enhanced adult immunization programs, driven by a growing recognition of the disease's resurgence among older populations. Governments are increasingly incorporating pertussis boosters into vaccination schedules for teens and adults, spurred by alarming epidemiological data indicating diminishing immunity and a rise in severe cases, particularly in vulnerable groups like pregnant women and the elderly. Public health initiatives aim to bridge immunity gaps, promote herd protection, and stimulate demand for next-generation vaccine formulations, effectively embedding pertussis vaccinations within routine adult health visits and workplace health initiatives, thereby broadening the market landscape.